# Research Motivation and Context

## Scientific Background

Schnéileopard is designed for Systems and Molecular Biomedicine research. This domain requires sophisticated data modeling and analysis capabilities that bridge molecular-level information with systems-level biological phenomena.

## Research Context

### Systems Biology

Systems biology approaches view cells and organisms as complex, interdependent networks. Key characteristics:

- **Information flow:** How signals propagate through molecular networks
- **Emergent properties:** Behaviors arising from network interactions
- **Multi-scale analysis:** Integrating data from molecular to organism level
- **Temporal dynamics:** How networks change in response to perturbations

Schnéileopard provides native domain types for:
- Molecular entities (genes, proteins, metabolites, variants)
- Network topologies and interactions
- Pathway membership and regulation
- Sample stratification and phenotyping

### Molecular Biomedicine

Molecular biomedicine focuses on disease mechanisms at the molecular level. Central questions include:

- What molecular alterations cause disease?
- How do variant and expression changes interact?
- Which samples cluster by molecular phenotype?
- Which features stratify patients by outcome?

Schnéileopard enables:
- Type-safe representation of molecular features
- Cohort-based analysis and stratification
- Feature ranking with statistical grounding
- Explainable predictions linking to molecular features

## Data Integration Challenges

Modern biomedical research integrates multiple modalities:

1. **Genomics:** DNA variation (SNP, CNV, structural variants)
2. **Transcriptomics:** mRNA abundance (bulk RNA-seq, single-cell)
3. **Proteomics:** Protein abundance and modifications
4. **Metabolomics:** Metabolite and lipid levels
5. **Phenotypes:** Disease outcomes, biomarkers, clinical traits
6. **Metadata:** Sample annotations, batch information, demographics

Schnéileopard's architecture:

- **Core types:** Identifiers and validation that work across modalities
- **Omics structures:** Flexible matrix representations for expression, protein, metabolite data
- **Cohort model:** Organizing samples with rich metadata
- **Graph layer:** Representing pathway relationships and interaction networks
- **AI interfaces:** Feature scoring and phenotype prediction that integrate modality-specific data

## Statistical Foundations

The AI layer in Schnéileopard is grounded in established statistical methods:

### Feature Ranking

- **Variance-based ranking:** High-variance features often distinguish biological states
- **Correlation analysis:** Features correlated with phenotype may be predictive or causal
- **Information-theoretic approaches:** Mutual information and entropy-based metrics

### Sample Stratification

- **Unsupervised clustering:** Discover natural sample groupings
- **Supervised classification:** Predict phenotypes from feature sets
- **Semi-supervised approaches:** Leverage unlabeled samples when labels are sparse

### Uncertainty Quantification

Research analysis must quantify confidence:
- **Calibrated probabilities:** Confidence scores reflect actual success rates
- **Credible intervals:** Uncertainty ranges rather than point estimates
- **Ensemble methods:** Robustness through aggregation

## Explainability Requirements

Biomedical research requires interpretable models:

1. **Feature attribution:** Which molecular features drove predictions?
2. **Sample selection:** Which samples influenced a decision?
3. **Network effects:** How do pathway relationships affect predictions?
4. **Biological validation:** Can predicted biomarkers be experimentally tested?

Schnéileopard encodes explanations as typed values, not black-box outputs.

## Reproducibility and Validation

Research integrity requires:

- **Deterministic computation:** Same input always produces same output
- **Parameter transparency:** Explicit configuration, not hidden hyperparameters
- **Version tracking:** Ability to reproduce exact computational environment
- **Data provenance:** Clear tracing from raw data to results

Schnéileopard design principles support reproducibility:

- No randomness in core algorithms (seeding required for stochastic methods)
- Configuration via immutable data structures
- Public API contracts through Scaladoc
- CI/CD integration for regression detection

## Computational Considerations

Biomedical datasets can be large:

- Expression matrices: 20,000 genes x 1,000,000 samples (challenging)
- Network analysis: 50,000+ nodes (scalable)
- Metadata queries: millions of samples (memory-bounded)

Schnéileopard design:

- Vector-based matrices (immutable, functional)
- Lazy evaluation opportunities (future versions)
- Streaming I/O support (future versions)
- Memory profiling and benchmarking

## Type-Safe Domain Modeling

Scientific code benefits from strong typing:

1. **Prevents semantic errors:** Cannot accidentally use gene ID where sample ID expected
2. **Documents intent:** API clearly shows what types are expected
3. **Enables refactoring:** Compiler catches changes rippling through codebase
4. **Facilitates testing:** Type signatures make it easier to generate test cases

Example: Distinguishing measurement modalities

```scala
// Type safe prevents mis-indexing
val expressionMatrix: ExpressionMatrix = ...
val feature: FeatureId = ...
val sample: SampleId = ...
val value: Double = expressionMatrix(featureIndex, sampleIndex)  // Cannot mix

// Allows specific validation for each modality
sealed trait Modality
case object Transcriptomics extends Modality
case object Proteomics extends Modality
// Each modality can have specific Analysis[M] implementations
```

## Integration with Scala Ecosystem

Schnéileopard is native to Scala:

- **Immutability by default:** Functional programming reduces bugs
- **Strong type system:** Catches errors at compile time
- **Pattern matching:** Elegant handling of result types
- **Scala collections:** Familiar, efficient data structures
- **Interoperability:** Java ecosystem access when needed

## Open Science Philosophy

Schnéileopard embodies open science principles:

1. **Open Source (EUPL 1.2):** Full source transparency, commercial-friendly
2. **Reproducible methods:** Algorithms documented, testable
3. **Community contributions:** Clear contribution guidelines
4. **Academic citation:** CITATION.cff for proper attribution
5. **Educational value:** Suitable for teaching computational biology

## Future Research Directions

Planned extensions:

### Short Term (0.2.x)
- Advanced stratification algorithms
- Additional explainability methods
- Performance optimizations

### Medium Term (1.0.x)
- Causal inference interfaces
- Temporal dynamics support
- Pathway analysis extensions

### Long Term (2.0.x)
- Federated learning support
- Multi-omics integration frameworks
- Biological validation pipelines

## References and Related Work

Schnéileopard builds on established practices in:

- **Bioinformatics:** BioConductor (R), Galaxy, GATK
- **Statistical genomics:** Limma, DESeq2, WGCNA approaches
- **Machine learning:** scikit-learn, TensorFlow/Keras patterns adapted for biology
- **Type systems:** Strongly typed approaches in systems biology (Scala ecosystem)

## Contact and Collaboration

For research discussions, collaborations, or methodology questions:

- Email: olaf.laitinen@uni.lu
- Department: Life Sciences and Medicine, University of Luxembourg
- ORCID: 0009-0006-5184-0810

## Acknowledgments

This work draws on methodological foundations from:
- University of Luxembourg Systems Medicine group
- International bioinformatics research community
- Scala functional programming ecosystem
- Academic best practices in open source software

---

*Research Motivation and Context - Last Updated: March 2026*
*Next Review: June 2026*
